- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Patent holdings for IPC class A61K 47/68
Total number of patents in this class: 9659
10-year publication summary
210
|
377
|
567
|
987
|
1218
|
1193
|
1401
|
1459
|
1409
|
416
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
SeaGen Inc | 554 |
215 |
Genentech, Inc. | 3742 |
184 |
Daiichi Sankyo Company, Limited | 1829 |
165 |
Regeneron Pharmaceuticals, Inc. | 3650 |
165 |
MedImmune Limited | 627 |
158 |
Hanmi Pharm. Co., Ltd. | 546 |
136 |
ImmunoGen, Inc. | 405 |
121 |
The Regents of the University of California | 18943 |
94 |
Dyne Therapeutics, Inc. | 157 |
92 |
Bristol-myers Squibb Company | 5080 |
87 |
Pfizer Inc. | 3322 |
79 |
Bolt Biotherapeutics, Inc. | 105 |
76 |
Novartis AG | 11238 |
75 |
ADC Therapeutics SA | 129 |
62 |
Abbvie Inc. | 1808 |
57 |
Mayo Foundation for Medical Education and Research | 2981 |
57 |
Hangzhou DAC Biotech Co., Ltd | 99 |
56 |
Hoffmann-La Roche Inc. | 3060 |
54 |
CytomX Therapeutics, Inc. | 205 |
54 |
Mersana Therapeutics, Inc. | 106 |
52 |
Other owners | 7620 |